2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
Michael Heuser(Martin Luther University Halle-Wittenberg), Jacqueline Cloos(Vrije Universiteit Amsterdam), Marta Libura(Medical University of Warsaw), Francesco Buccisano(University of Rome Tor Vergata), Christian Thiede(University Hospital Carl Gustav Carus), Michaela Feuring‐Buske(University Hospital Ulm), Gail J. Roboz(Cornell University), Francis Lacombe, Arjan A. van de Loosdrecht(Dutch Cancer Society), Roland B. Walter(Rafael Advanced Defense Systems (Israel)), Brent L. Wood(University of Southern California), Adriana Pleșa(Hospices Civils de Lyon), Agnieszka Wierzbowska(Medical University of Lodz), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Marina Konopleva(Albert Einstein College of Medicine), Anna Czyż(Wroclaw Medical University), Lok Lam Ngai(Dutch Cancer Society), Barbara Denys(Ghent University), Sylvie Freeman(University of Birmingham), Jeffrey L. Jorgensen(The University of Texas MD Anderson Cancer Center), Luca Maurillo(University of Rome Tor Vergata), Yishai Ofran(Shaare Zedek Medical Center), Veit Bücklein(LMU Klinikum), Christophe Roumier(Université de Lille), Constance Baer(Munich Leukemia Laboratory (Germany)), Costa Bachas(Amsterdam University Medical Centers), Torsten Haferlach(Martin Luther Christian University), Jesse M. Tettero(Amsterdam Neuroscience), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Bert A. van der Reijden(Radboud University Nijmegen), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Konstanze Döhner(University Hospital Ulm), Felicitas Thol(Medizinische Hochschule Hannover), Christopher S. Hourigan(National Heart Lung and Blood Institute), Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Jan Philippé(Ghent University), Peter J.M. Valk(Erasmus MC Cancer Institute), Agata Majchrzak(Copernicus Memorial Hospital), Julia Herzig(University Hospital Ulm), Lina Han(Hebei Medical University), Marion Subklewe(LMU Klinikum), Gert J. Ossenkoppele(Dutch Cancer Society), Richard Dillon(King's College London), Adriano Venditti(University of Rome Tor Vergata), Farhad Ravandi(The University of Texas MD Anderson Cancer Center)
Cited by 714
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k